PCI Pharma Services makes $1B investment to scale injectable manufacturing, device assembly
From prefilled syringes to autoinjectors, the CDMO is expanding capacity in the U.S. and Europe as self-administered therapies gain traction.
Read the full article on the original site.
Read Full Article